Research output per year
Research output per year
Search results
-
2021
Clinical and immunologic implications of COVID-19 in patients with melanoma and renal cell carcinoma receiving immune checkpoint inhibitors
Switzer, B., Haanen, J., Lorigan, P. C., Puzanov, I. & Turajlic, S., 16 Jul 2021Research output: Other contribution › peer-review
Open Access -
2011
Adjuvant therapy for malignant melanoma-MAGE.A3 vaccines and bevacizumab
Lorigan, P., 2011Research output: Other contribution › peer-review
Open Access -
2002
A randomized study of temozolomide (TMX) alone, with interferon-alpha (TMZ-IFN) or with thalidomide (TMZ-THL) in metastatic malignant melanoma (MMM)
Danson, S., Arance, A., Lorigan, P., Clamp, A., Hodgetts, J., Lomax, L., Thatcher, N. & Middleton, M., 2002Research output: Other contribution › peer-review